Blood glucose levels in patients with metastatic renal cell carcinoma treated with sunitinib

por Billemont, B, Medioni, J, Taillade, L, Helley, D, Meric, J B, Rixe, O, Oudard, S
Publicado 2008

Biological toxicities as surrogate markers of efficacy in patients treated with mTOR inhibitors for metastatic renal cell carcinoma

por Jebali, M., Elaidi, R., Brizard, M., Fouque, J., Takouchop, C., Sabatier, B., Oudard, S., Medioni, J.
Publicado 2017

Low immunogenicity of seasonal trivalent influenza vaccine among patients receiving docetaxel for a solid tumour: results of a prospective pilot study

por Loulergue, P, Alexandre, J, Iurisci, I, Grabar, S, Medioni, J, Ropert, S, Dieras, V, Le Chevalier, F, Oudard, S, Goldwasser, F, Lebon, P, Launay, O
Publicado 2011

Correlation between genetic alterations and growth of human malignant glioma xenografted in nude mice

por Leuraud, P, Taillandier, L, Aguirre-Cruz, L, Medioni, J, Crinière, E, Marie, Y, Dutrillaux, A M, Kujas, M, Duprez, A, Delattre, J-Y, Poupon, M-F, Sanson, M
Publicado 2003

Preexisting autoantibodies as predictor of immune related adverse events (irAEs) for advanced solid tumors treated with immune checkpoint inhibitors (ICIs)

por Daban, A, Gonnin, C, Phan, L, Saldmann, A, Granier, C, Lillo-Lelouet, A, Le Beller, C, Pouchot, J, Weiss, l, Tartour, E, Fabre, E, Medioni, J, Oudard, S, Vano, YA, Dragon-Durey, MA, Simonaggio, A.
Publicado 2023